» Articles » PMID: 23217872

Risk Factors Affecting Late-presenting Liver Failure in Adult Patients with Biliary Atresia

Overview
Journal J Pediatr Surg
Date 2012 Dec 11
PMID 23217872
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Following the Kasai operation, a number of patients have developed liver failure, even after long-term postoperative courses. We assessed the clinical parameters to clarify the early risk factors affecting late-presenting liver failure in biliary atresia.

Materials And Methods: From 1955 to 1991, 277 patients underwent a Kasai operation. Among those patients, 92 survived with their native liver for more than 20 years, and 72 continue to survive with their native liver in good condition (Group 1). In 20 patients, persistent jaundice recurred after the age of 20 years (Group 2). The postoperative courses of these patients were assessed retrospectively, and the clinical parameters, including age at the time of the Kasai operation (AGE, days), the period required for jaundice to disappear (PJD, days), and the association with early cholangitis (CG), were compared between the 2 groups.

Results: Of the 20 patients in Group 2, 8 survived after a liver transplantation (LTx). Eight patients had recurrent jaundice, including 4 on the waiting list for anLTx. Additionally, 2 patients died after anLTx at the ages of 22 and 39. Another patient died of liver failure at the age of 28. One patient died of massive esophageal variceal bleeding at the age of 29. Significant differences were confirmed with respect to AGE (Group 1<Group 2, p<.001), PJD (Group 1<Group 2, p<.001), and CG (Group 1: Group 2=47 %: 75 %, p=.028).

Conclusions: A considerable number of adult patients developed liver failure, even after the age of 20 years. AGE, PJD, and CG were found to be risk factors affecting late-presenting liver failure. Therefore, close patient follow-up is essential, especially for long-term survivors with a late operative age and early postoperative complications.

Citing Articles

Retrospective analysis of the standardized BARD criteria for acute cholangitis in biliary atresia patients.

Madadi-Sanjani O, Calinescu A, Rock N, McLin V, Uecker M, Kuebler J JPGN Rep. 2024; 5(3):309-316.

PMID: 39149194 PMC: 11322016. DOI: 10.1002/jpr3.12071.


Outcomes of adult native liver survivors with biliary atresia: the current situation in Japan.

Kawaguchi Y, Terui K, Takenouchi A, Komatsu S, Saito T, Hishiki T Pediatr Surg Int. 2023; 39(1):263.

PMID: 37668658 DOI: 10.1007/s00383-023-05551-6.


Cholangitis Definition and Treatment after Kasai Hepatoportoenterostomy for Biliary Atresia: A Delphi Process and International Expert Panel.

Calinescu A, Madadi-Sanjani O, Mack C, Schreiber R, Superina R, Kelly D J Clin Med. 2022; 11(3).

PMID: 35159946 PMC: 8836553. DOI: 10.3390/jcm11030494.


Machine Learning Evaluation of Biliary Atresia Patients to Predict Long-Term Outcome after the Kasai Procedure.

Caruso M, Ricciardi C, Delli Paoli G, Di Dato F, Donisi L, Romeo V Bioengineering (Basel). 2021; 8(11).

PMID: 34821718 PMC: 8615125. DOI: 10.3390/bioengineering8110152.


Liver Transplantation for Biliary Atresia in Adulthood: Single-Centre Surgical Experience.

Cortes-Cerisuelo M, Boumpoureka C, Cassar N, Joshi D, Samyn M, Heneghan M J Clin Med. 2021; 10(21).

PMID: 34768489 PMC: 8584637. DOI: 10.3390/jcm10214969.